ITUB20160203A1 - Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso. - Google Patents

Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.

Info

Publication number
ITUB20160203A1
ITUB20160203A1 ITUB2016A000203A ITUB20160203A ITUB20160203A1 IT UB20160203 A1 ITUB20160203 A1 IT UB20160203A1 IT UB2016A000203 A ITUB2016A000203 A IT UB2016A000203A IT UB20160203 A ITUB20160203 A IT UB20160203A IT UB20160203 A1 ITUB20160203 A1 IT UB20160203A1
Authority
IT
Italy
Prior art keywords
formulations
modified
preparation
containing high
tablets containing
Prior art date
Application number
ITUB2016A000203A
Other languages
English (en)
Inventor
Roberto Valducci
Serozh Avanessian
Original Assignee
Valpharma Int Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valpharma Int Spa filed Critical Valpharma Int Spa
Priority to ITUB2016A000203A priority Critical patent/ITUB20160203A1/it
Priority to PCT/IB2017/050253 priority patent/WO2017125856A1/en
Publication of ITUB20160203A1 publication Critical patent/ITUB20160203A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
ITUB2016A000203A 2016-01-19 2016-01-19 Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso. ITUB20160203A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITUB2016A000203A ITUB20160203A1 (it) 2016-01-19 2016-01-19 Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.
PCT/IB2017/050253 WO2017125856A1 (en) 2016-01-19 2017-01-18 Formulations in modified-release tablets containing high-dosage mesalazine, process for their preparation and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000203A ITUB20160203A1 (it) 2016-01-19 2016-01-19 Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.

Publications (1)

Publication Number Publication Date
ITUB20160203A1 true ITUB20160203A1 (it) 2017-07-19

Family

ID=55795093

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2016A000203A ITUB20160203A1 (it) 2016-01-19 2016-01-19 Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.

Country Status (2)

Country Link
IT (1) ITUB20160203A1 (it)
WO (1) WO2017125856A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800011120A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione di mesalazina o suoi derivati
US11975011B2 (en) * 2020-11-03 2024-05-07 Atoz Pharmaceuticals Pvt Ltd Matrix mesalamine extended release minitablets and its process thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004297A1 (en) * 1998-11-13 2000-05-31 LABORATORIO FARMACEUTICO C.T. S.r.l. Pharmaceutical compositions for oral administration containing a gastroresistant coating based on acrylic polymers
EP2468264A1 (en) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004297A1 (en) * 1998-11-13 2000-05-31 LABORATORIO FARMACEUTICO C.T. S.r.l. Pharmaceutical compositions for oral administration containing a gastroresistant coating based on acrylic polymers
EP2468264A1 (en) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Mezavant XL 1200mg, gastro-resistant, prolonged release tablets", WWW.MEDICINES.ORG.UK, 20 October 2014 (2014-10-20), pages 1 - 9, XP055301047, Retrieved from the Internet <URL:https://www.medicines.org.uk/emc/print-document?documentId=20347> [retrieved on 20160908] *

Also Published As

Publication number Publication date
WO2017125856A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
HK1246309A1 (zh) 去免疫化的志賀毒素a亞基支架和包含它們的細胞靶向分子
EP3505519A4 (en) PYRIDINAMINE-SUBSTITUTED HETEROTRICYCLO COMPOUNDS, PRODUCTION THEREOF AND USE IN MEDICINAL PRODUCTS
HK1255566A1 (zh) 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用
IL263709A (en) Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
EP3524603A4 (en) FGFR4 INHIBITOR, PRODUCTION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
ECSP17084331A (es) Formulaciones farmacéuticas
BR112016014595A2 (pt) material à base de sólido para uso tópico sobre a pele,composição aquosa e método de produção do mesmo.
BR112015031979A2 (pt) letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir.
GB201620066D0 (en) Solid Pharmaceutical dosage formulations and processes
MA42303A (fr) Formulations pharmaceutiques
MA46867A (fr) Formulations pharmaceutiques
DK3558260T3 (da) Kosmetisk sammensætning omfattende et chaga-ekstrakt og anvendelse deraf
EP3278799A4 (en) Docetaxol albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereof
SI3426294T1 (sl) Farmacevtska formulacija, ki vsebuje protitelesa, ciklodekstrin in metionin
EP3265059A4 (en) Combination liposomal pharmaceutical formulations
EP3560918A4 (en) TRIAZOLE DERIVATIVE FROM THE CONDENSED CYCLE AZACYCLOBUTYL GROUP, PREPARATION METHOD THEREOF AND USE IN MEDICINE
BR112018005299A2 (pt) 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso
BR112014020008A8 (pt) composição farmacêutica, uso da mesma, e, processo para a fabricação de uma formulação.
ITUB20160203A1 (it) Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.
EP3476864A4 (en) ANTIBODIES AGAINST ETAR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
CY1118277T1 (el) Σταθερη φαρμακοτεχνικη μορφη πεξιγανανης
HK1244275A1 (zh) 咪唑並嘧啶和咪唑並三嗪衍生物和包含其的藥物組合物
ITUA20164369A1 (it) Nuovi derivati aza-tanshinonici, procedimento per la loro preparazione e loro uso in terapia.
GB201609968D0 (en) Topical pharmaceutical formulation